Soft tissue repair · Foot & ankle
Radical resection of a soft tissue tumor of the leg or ankle, where the tumor and surrounding margin of normal tissue measure 5 cm or larger.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $1,158.68
- Total RVUs
- 34.69
- Global, days
- 90
- Region
- Foot & ankle
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Preoperative imaging (MRI preferred) confirming tumor size, location, and tissue involvement in the leg or ankle region
- Operative note documenting the surgical approach, anatomic boundaries of resection, and explicit specimen dimensions (must be 5 cm or greater)
- Pathology report confirming tissue type and margin status — links medical necessity to the radical resection approach
- Diagnosis code (ICD-10) consistent with malignant or aggressive soft tissue neoplasm of the leg or ankle
- Post-op plan documenting follow-up within the 90-day global period, with any separately billable services flagged with appropriate modifiers
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 27616 covers radical resection of a soft tissue tumor — typically a malignant neoplasm — of the leg (tibia/fibula region) or ankle, with a resected specimen of 5 cm or greater. Radical resection means en bloc removal of the tumor with a cuff of normal surrounding tissue, not simple excision or debridement. The size threshold distinguishes 27616 from its smaller-specimen counterpart; if the resected mass is under 5 cm, a different code applies.
This is a high-complexity soft tissue procedure carrying a 90-day global period. All routine post-op visits, wound checks, and dressing changes through day 90 are bundled. Anything unrelated to the tumor resection billed during the global window requires modifier 24 (E/M) or modifier 79 (unrelated procedure). An unplanned return to the OR for a related complication — say, wound dehiscence or hematoma — uses modifier 78.
Documentation must establish medical necessity through imaging and pathology correlation, confirm the surgical approach and anatomic location, and record the specimen size explicitly. Operative notes that omit tumor dimensions or describe margins vaguely are the primary audit target for this code.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 19.14 |
| Practice expense RVU | 11.38 |
| Malpractice RVU | 4.17 |
| Total RVU | 34.69 |
| Medicare national rate | $1,158.68 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $1,158.68 |
HOPD (APC 5073) Hospital outpatient department | $2,967.63 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $1,248.36 |
Common denial reasons
The recurring reasons claims for CPT 27616 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Specimen size not documented or ambiguous — payer downcodes to the sub-5 cm code without an explicit measurement in the operative note
- CPT-ICD-10 mismatch — using a benign tumor diagnosis code with a radical resection code triggers medical necessity denial
- Unbundling of incidental procedures performed at the same site without a modifier 59 or XS where an NCCI PTP edit applies
- Global period violations — billing a related E/M or wound care visit within 90 days without modifier 24 or 78 as appropriate
- Site-of-service mismatch between the claim and the facility where the procedure was performed
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What distinguishes 27616 from the smaller-tumor leg/ankle resection code?
02Does 'radical resection' require confirmed malignancy on pathology before billing?
03Can 27616 be billed the same day as a bone resection or reconstructive procedure?
04How does the 90-day global period affect post-op oncology follow-up visits?
05Is 27616 billable bilaterally, and how should bilateral cases be reported?
06What modifier applies if the surgeon returns to the OR for wound complications after 27616?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02aapc.comhttps://www.aapc.com/codes/cpt-codes/27616
- 03findacode.comhttps://www.findacode.com/cpt/27616-cpt-code.html
- 04mdclarity.comhttps://www.mdclarity.com/cpt-code/27616
- 05cms.govhttps://www.cms.gov/files/document/04-chapter4-ncci-medicare-policy-manual-2025finalcleanpdf.pdf
- 06aaos.orghttps://www.aaos.org/globalassets/quality-and-practice-resources/coding-and-reimbursement/resident-guide/resident-guide-coding-reference-tools_what-is-ncci-mue_050125.pdf
Mira AI Scribe
Mira's AI scribe captures tumor location (leg vs. ankle), resection margins, specimen size in centimeters, and surgical approach from dictation — directly preventing downcoding to the sub-5 cm code due to missing dimensions. It also flags the 90-day global start date so billing staff can apply modifiers 24, 78, or 79 correctly on subsequent claims.
See how Mira captures CPT 27616 documentation